Literature DB >> 30701968

Metabolization of the Advanced Glycation End Product N-ε-Carboxymethyllysine (CML) by Different Probiotic E. coli Strains.

Michael Hellwig1, Christian Auerbach2, Nicole Müller1,2, Pauline Samuel1,2, Sophie Kammann1,2, Falco Beer1, Florian Gunzer2, Thomas Henle1.   

Abstract

N-ε-Carboxymethyllysine (CML) is formed during glycation reactions (synonym, Maillard reaction). CML is degraded by the human colonic microbiota, but nothing is known about the formation of particular metabolites. In the present study, six probiotic E. coli strains were incubated with CML in the presence or absence of oxygen in either minimal or nutrient-rich medium. CML was degraded by all strains only in the presence of oxygen. HPLC-MS/MS was applied for identification of metabolites of CML. For the first time, three bacterial metabolites of CML have been identified, namely N-carboxymethylcadaverine (CM-CAD), N-carboxymethylaminopentanoic acid (CM-APA), and the N-carboxymethyl-Δ1-piperideinium ion. During 48 h of incubation of CML with five different E. coli strains in minimal medium in the presence of oxygen, 37-66% of CML was degraded, while CM-CAD (1.5-8.4% of the initial CML dose) and CM-APA (0.04-0.11% of the initial CML dose) were formed linearly. Formation of the metabolites is enhanced when dipeptide-bound CML is applied, indicating that transport phenomena may play an important role in the "handling" of the compound by microorganisms.

Entities:  

Keywords:  E. coli; Maillard reaction; N-ε-carboxymethyllysine (CML); biogenic amine; metabolism; probiotic strain

Mesh:

Substances:

Year:  2019        PMID: 30701968     DOI: 10.1021/acs.jafc.8b06748

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  5 in total

1.  Biocatalytic Reversal of Advanced Glycation End Product Modification.

Authors:  Nam Y Kim; Tyler N Goddard; Seungjung Sohn; David A Spiegel; Jason M Crawford
Journal:  Chembiochem       Date:  2019-08-09       Impact factor: 3.164

Review 2.  Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.

Authors:  Aleksandra Twarda-Clapa; Aleksandra Olczak; Aneta M Białkowska; Maria Koziołkiewicz
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

3.  A 4-Week Diet Low or High in Advanced Glycation Endproducts Has Limited Impact on Gut Microbial Composition in Abdominally Obese Individuals: The deAGEing Trial.

Authors:  Armand M A Linkens; Niels van Best; Petra M Niessen; Nicole E G Wijckmans; Erica E C de Goei; Jean L J M Scheijen; Martien C J M van Dongen; Christel C J A W van Gool; Willem M de Vos; Alfons J H M Houben; Coen D A Stehouwer; Simone J M P Eussen; John Penders; Casper G Schalkwijk
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

4.  Inter- and Intraindividual Differences in the Capacity of the Human Intestinal Microbiome in Fecal Slurries to Metabolize Fructoselysine and Carboxymethyllysine.

Authors:  Katja C W van Dongen; Clara Belzer; Wouter Bakker; Ivonne M C M Rietjens; Karsten Beekmann
Journal:  J Agric Food Chem       Date:  2022-09-07       Impact factor: 5.895

5.  Habitual intake of dietary advanced glycation end products is not associated with generalized microvascular function-the Maastricht Study.

Authors:  Armand M A Linkens; Alfons J H M Houben; Abraham A Kroon; Miranda T Schram; Tos T J M Berendschot; Carroll A B Webers; Marleen van Greevenbroek; Ronald M A Henry; Bastiaan de Galan; Coen D A Stehouwer; Simone J M P Eussen; Casper G Schalkwijk
Journal:  Am J Clin Nutr       Date:  2022-02-09       Impact factor: 7.045

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.